Recent Finacing
Recent Raise
SmartCella develops the FDA-cleared Extroducer endovascular device for direct infusion to hard-to-reach organs and tumors and operates targeted delivery and cell/mRNA therapy units.
Focus Areas
Recent Investors
Valuation as of 07/08/2024
Total Raised
Funding round
Investors
See the team members at SmartCella.